WVE Q4 2025 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M-79.4% YoY

Gross Profit

$15M86.9% margin

Operating Income

-$56M-327.4% margin

Net Income

-$53M-308.4% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+126.7%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$638M

Total Liabilities

$112M

Stockholders' Equity

$526M

Cash & Equivalents

$602M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$84M	-79.4%
Gross Profit	$15M	$84M	-82.1%
Operating Income	-$56M	$23M	-345.9%
Net Income	-$53M	$29M	-281.8%